The François Jacob Institute of Biology brings together five departments and three services
The last two years in scientific news
OncoDesign is a biopharmaceutical company engaged in the discovery of effective therapies for the benefit of patients with pathology without therapeutic solution.
Pioneers of translational medicine, from the creation of new experimental models to the development of new approaches to assess the efficacy of treatments, such as pharmaco-imaging. OncoDesign is particularly interested in kinases, a family of key enzymes in the maintenance of cellular homeostasis: their deregulation is at the origin of many pathologies. OncoDesign develops both potent and specific inhibitors of the targeted kinases, which are then tested for their therapeutic potential.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.